(Q43455968)

23 November 2017

title

Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy (English)

1 reference

23 November 2017

main subject

congestive heart failure

1 reference

7

Reinhard Kandolf

1 reference

23 November 2017

6

Karin Klingel

1 reference

23 November 2017

9

Meinrad Gawaz

1 reference

23 November 2017

4

Tobias Geisler

1 reference

23 November 2017

Christine S Zuern

1

1 reference

23 November 2017

Karin A L Müller

2

1 reference

23 November 2017

Peter Seizer

3

1 reference

23 November 2017

Winston Banya

5

1 reference

23 November 2017

Axel Bauer

8

1 reference

23 November 2017

Andreas E May

10

1 reference

23 November 2017

language of work or name

1 reference

12 December 2012

1 reference

European Journal of Heart Failure

23 November 2017

published in

1 reference

23 November 2017

volume

15

1 reference

23 November 2017

issue

2

1 reference

23 November 2017

page(s)

176-184

1 reference

From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Relation between gender, etiology and survival in patients with symptomatic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Progression of familial and non-familial dilated cardiomyopathy: long term follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Predictors of outcome in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Cyclophilin: a specific cytosolic binding protein for cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Disrupting the EMMPRIN (CD147)-cyclophilin A interaction reduces infarct size and preserves systolic function after myocardial ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Dealing with the family: CD147 interactions with cyclophilins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Active site residues of cyclophilin A are crucial for its signaling activity via CD147

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

A standardized definition of ischemic cardiomyopathy for use in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Molecular pathology of inflammatory cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Interferon beta modulates endothelial damage in patients with cardiac persistence of human parvovirus b19 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFS185

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFS185

1 reference

23 November 2017

1 reference